Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
Her Z, Teng TS, Tan JJ, Teo TH, Kam YW, Lum FM, Lee WW, Gabriel C, Melchiotti R, Andiappan AK, Lulla V, Lulla A, Win MK, Chow A, Biswas SK, Leo YS, Lecuit M, Merits A, Rénia L, Ng LF.
Her Z, et al. Among authors: chow a.
EMBO Mol Med. 2015 Jan;7(1):24-41. doi: 10.15252/emmm.201404459.
EMBO Mol Med. 2015.
PMID: 25452586
Free PMC article.